Influenza - Pipeline Review, Q1 2011 (Related Reports)

Influenza - Pipeline Review, Q1 2011


February 28, 2011
131 Pages - SKU: GMD6185846
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
4/1/2014 | published by: FirstWord
Introduction Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in  |  read more...
$4,995.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Pertussis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Pertussis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2014’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative  |  read more...
$2,000.00
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014’, provides an overview of the Klebsiella Pneumoniae Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Polio - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polio - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polio - Pipeline Review, H1 2014’, provides an overview of the Polio’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polio, complete with comparative  |  read more...
$2,000.00
Typhoid Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
$2,000.00
Perennial Allergic Rhinitis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H1 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Severe Psoriasis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Severe  |  read more...
$2,000.00
Yellow Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Yellow Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2014’, provides an overview of the Yellow Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Yellow  |  read more...
$2,000.00
Tourette Syndrome - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Tourette Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2014’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tourette  |  read more...
$2,000.00